Back
Boston Properties Vs. Cytokinetics Industry Stock Comparison
Sell
42
BXP
Boston Properties
Last Price:
61.65
Seasonality Move:
0.82%
Buy
55
CYTK
Cytokinetics
Last Price:
53.96
Seasonality Move:
7.55%
Sell
42
Boston Properties (BXP)
is a Sell
Is Boston Properties a Buy, Sell or Hold?
- The current Boston Properties [BXP] share price is $61.64. The Score for BXP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- BXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BXP Stock Price Chart
What is Boston Properties's stock price today?
-
The Boston Properties share price today is $61.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BXP is experiencing slight buying pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
BXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | 393296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.82 - 62.72) | Buy |
| Bollinger Bands (100): | (59.93 - 65.79) | Sell |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 46.58 | Sell |
| Chaikin Money Flow: | 781761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.51 - 58.99) | Sell |
| Bollinger Bands (100): | (57.71 - 76.51) | Sell |
BXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.02 | Buy |
| 20-day SMA: | 60.14 | Buy |
| 50-day SMA: | 60.92 | Buy |
| 200-day SMA: | 62.3 | Sell |
| 8-day EMA: | 60.3 | Buy |
| 20-day EMA: | 60.33 | Buy |
| 50-day EMA: | 61.13 | Buy |
| 200-day EMA: | 62.69 | Sell |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.47 | Buy |
| 20-day SMA: | 52.83 | Buy |
| 50-day SMA: | 60.85 | Sell |
| 200-day SMA: | 55.3 | Sell |
| 8-day EMA: | 53.07 | Buy |
| 20-day EMA: | 54.08 | Sell |
| 50-day EMA: | 58.8 | Sell |
| 200-day EMA: | 57.11 | Sell |
Boston Properties Earnings Growth & BXP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.43 per share, and an increase next year of $0.17 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.
Boston Properties Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||